Every SEC Form 3/4/5 on record for this filer (CIK 1669207) — 5 issuers, 38 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| BLFS | BIOLIFE SOLUTIONS INC | Director | 2022-09-06 → 2026-02-26 | 8 | — |
| CERS | CERUS CORP | Director | 2018-09-07 → 2025-06-04 | 15 | $32,165 |
| ALLO | Allogene Therapeutics, Inc. | Chief Technical Officer | 2023-04-26 → 2025-02-05 | 5 | −$25,216 |
| TIL | Instil Bio, Inc. | Chief Operating Officer · lapsed | 2022-09-06 → 2022-09-06 | 2 | — |
| KITE | Kite Pharma, Inc. | EVP, Technical Operations · lapsed | 2016-03-16 → 2017-10-05 | 7 | −$3M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ALLO | 2025-02-03 | Sell | 14,746 | $1.71 | $25,216 | 250,713 |
4 of 5 issuers are covered and open a security page; the rest are on file here only.